PEM
Kintai Therapeutics, Inc.
Mark For: PEM® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88393507 |
| Registration Number | 1501311 |
| Mark Literal Elements | PEM |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2020-01-21 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Christina M. Licursi |
| Attorney Docket Number | V03132000400 |
Timeline
| 2019-04-19 | Application Filed |
| 2019-04-23 | Location: NEW APPLICATION PROCESSING |
| 2019-04-23 | Status: Live/Pending |
| 2019-04-25 | Transaction Date |
| 2019-11-26 | Published |
| 2019-11-26 | Published for Opposition |
| 2020-01-21 | Location: INTENT TO USE SECTION |
| 2020-01-21 | Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six |
Trademark Parties (Applicants & Owners)
| Party: |  Kintai Therapeutics, Inc. |
| Address | 26 Landsdowne St, Suite 450 Cambridge, MASSACHUSETTS UNITED STATES 02139 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | JPEG | 2019-04-19 |
 TEAS RF New Application | MULTI | 2019-04-19 |
| Notation to File | XML | 2019-06-28 |
| Offc Action Outgoing | XML | 2019-06-28 |
| XSearch Search Summary | XML | 2019-06-28 |
| Response to Office Action | APPLICATION/XML | 2019-10-16 |
| Amendment and Mail Process Complete | MULTI | 2019-10-17 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-10-18 |
| Notice of Publication | XML | 2019-11-06 |
| Notification Of Notice of Publication | XML | 2019-11-06 |
| OG Publication Confirmation | XML | 2019-11-26 |
| Notice of Allowance | APPLICATION/XML | 2020-01-21 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use
IC 042. US 100 101. G & S: Research and development in the field of computational biology, biotechnology and pharmaceuticals
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Therapeutic products for the treatment of disease; pharmaceutical preparations for the treatment of disease; therapeutic products to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; agents that modulate metabolism for scientific and research use; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-01-21 | |
| PUBLISHED FOR OPPOSITION | 2019-11-26 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-11-26 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-11-06 | |
| ASSIGNED TO LIE | 2019-10-23 | 70884 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-10-17 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-10-16 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-10-16 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-10-16 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-06-28 | 6325 |
| NON-FINAL ACTION WRITTEN | 2019-06-28 | 83698 |
| NON-FINAL ACTION E-MAILED | 2019-06-28 | 6325 |
| ASSIGNED TO EXAMINER | 2019-06-28 | 83698 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-05-06 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-04-23 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 